Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SAN:PAR since
Tidal Therapeutics IncDeal completed09 Apr 202109 Apr 2021Deal completed1.77%470.00m
Kymab Group LtdDeal completed11 Jan 202111 Jan 2021Deal completed9.42%1.45bn
Kiadis Pharma NVAnnounced02 Nov 202002 Nov 2020Announced11.43%254.17m
Principia Biopharma IncDeal completed17 Aug 202017 Aug 2020Deal completed0.88%3.67bn
Data delayed at least 15 minutes, as of Apr 19 2021 16:35 BST.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.